InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Nau Jeffrey, Chief Executive Officer. Director active across 2 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 6 disclosures have been logged. The latest transaction was disclosed on 9 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
046,700 shares0
Common Stock
SEC:0001209191-22-002979:0·
046,700 shares0
Common Stock
SEC:0001209191-22-002979·
€43,87050,000 shares@ €0.877483.6% of flow
Common Stock
SEC:0001209191-21-061371·
€43,87050,000 shares@ €0.877441.8% of flow
Common Stock
SEC:0001209191-21-061371:0·
€8,61410,000 shares@ €0.861416.4% of flow
Common Stock
SEC:0001209191-21-054298·
€8,61410,000 shares@ €0.86148.2% of flow
Common Stock
SEC:0001209191-21-054298:0·
6 of 6 declarations
About Nau Jeffrey
Jeffrey Nau is the President and Chief Executive Officer of Oyster Point Pharma, Inc. He leads the strategic operations of the company, focusing on innovation and growth. His leadership is essential in guiding Oyster Point to new heights.
